ReviewCancers2019

Progression-Free but No Overall Survival Benefit for Adult Patients with Bevacizumab Therapy for the Treatment of Newly Diagnosed Glioblastoma: A Systematic Review and Meta-Analysis.

Nagham Kaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.